期刊文献+

桃红四物汤对乳腺癌血管生成的影响 被引量:13

Effect of Tao Hong Siwu Decoction on Angiogenesis in Patients with Breast Cancer
原文传递
导出
摘要 【目的】探讨桃红四物汤对乳腺癌血管生成的影响及机理。【方法】将行术前化疗的40例乳腺癌患者随机分为治疗组和对照组。治疗组20例给予桃红四物汤及术前化疗,对照组20例单纯行术前化疗。观察各组患者化疗前及化疗3个疗程后(21 d为1个疗程)肿瘤的微血管密度(MVD)、血管内皮生长因子(VEGF-A)、血管内皮生长因子受体-1(flk-1)的表达变化。【结果】治疗后2组均能降低MVD、VEGF-A的表达,与治疗前比较差异均有统计学意义(P<0.05);治疗后2组比较,治疗组MVD及VEGF-A表达阳性率均显著低于对照组,差异有统计学意义(P<0.05)。治疗后2组亦能降低flk-1表达,但差异无统计学意义(P>0.05),治疗后2组比较差异无统计学意义(P>0.05)。【结论】桃红四物汤能抑制乳腺癌患者肿瘤血管生成,其作用机制可能与抑制VEGF-A及MVD表达有关。 Objective To study the effect of Tao Hong Siwu Decoction on the tumor angiogenesis and to explore its mechanism. Methods Forty breast cancer patients who had received preoperative chemotherapy were equally randomized into two groups. The treatment group was given oral use of Tao Hong Siwu Decoction and preoperative chemotherapy, and the control group was given only preoperative chemotherapy, 21 days constituting one treatment course. The micro-vessle density ( MVD ) , and the expression levels of vascular endothelial growth factor A (VEGF-A) and vascular endothelial growth factor receptor 1 (ilk-1) in the tumor tissue of both groups were observed before chemotherapy and after 3 courses of chemotherapy. Results After treatment, both groups decreased MVD and the expression level of VEGF-A in tumor tissue (P 〈 0. 05 compared with those before treatment), and the difference between the two groups was statistically significant (P 〈 0.05 ). The expression of ilk-1 in the tumor tissue was decreased in both groups, but the difference was insignificant (P 〉 0.05 ). Conclusion Tao Hong Siwu Decoction can inhibit the angiogenesis in the tumor tissue of patients with breast cancer, and its mechanism is associated with the inhibition of VEGF-A expression and with the decrease of MVD.
出处 《广州中医药大学学报》 CAS 北大核心 2012年第6期623-626,共4页 Journal of Guangzhou University of Traditional Chinese Medicine
基金 广东省科技计划项目(编号:20090315)
关键词 桃红四物汤 治疗应用 术前化疗 抗血管生成 微血管密度 血管内皮生长因子 血管内皮生长因子受体-1 TAO HONG SIWU DECOCTION/therapeutic use PREOPERATIVE CHEMOTHERAPY ANTI-ANGIOGENESIS VASCULAR ENDOTHELIAL GROWTH FACTOR VASCULAR ENDOTHELIALGROWTH FACTOR RECEFFOR 1
  • 相关文献

参考文献7

  • 1Dai J,Rabie A B. VEGF : an essential mediator of bothangiogenesis and endochondral ossification [ J ] . J Dent Res,2007,86 (10) : 937.
  • 2Yancopoulos G D, Davis S, Gale N W, et al. Vascular - specific growth factors and blood vessel formation [ J ] . Nature,2000, 407: 242.
  • 3Linderholm B K,Lindahl T, Holmberg L, et al. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer [ J]. Cancer Res, 2001, 61: 2256.
  • 4耿振英,张侠.高凝状态与恶性肿瘤[J].中国微循环,2008,12(5):323-325. 被引量:25
  • 5Elalamy I, Verdy E, Gerotziafas G, et al. Pathogenesis of venousthromboembolic diseases in cancer [ J ]. Pathol Biol ( Pairs), 2008,56 (4) : 184.
  • 6李公一.桃红四物汤治验[J].现代中西医结合杂志,2008,17(3):420-421. 被引量:3
  • 7王淑美,徐晓玉,张文亮,胡益勇,陈伟海.桃红四物汤及其拆方对血管生成的影响[J].中药药理与临床,2005,21(4):4-7. 被引量:28

二级参考文献28

  • 1安小玲,李军,董红,唐杰.糖尿病视网膜病变中氧化应激反应的研究及应用[J].眼科新进展,2004,24(6):441-443. 被引量:4
  • 2任元富.血栓前状态的诊断与治疗[J].中国社区医师(医学专业),2005,7(14):2-3. 被引量:1
  • 3潘磊,王勇,孙越,邓新力.经鼻无创正压通气治疗阻塞性睡眠呼吸暂停综合征血栓前状态效果评价[J].中国实用内科杂志,2006,26(7):1015-1017. 被引量:18
  • 4白丽萍,门剑龙.恶性转移瘤患者高凝状态的研究[J].中国慢性病预防与控制,2006,14(4):241-242. 被引量:19
  • 5Collen D. On the regulation and control offibrinolysis [ J ] . Thromb Hemost, 1980,43 (2) :77-89.
  • 6Verena Pihusch, Markus Pihusch, Marius Penovici, et al. Transforming growth factor beta- 1 released from platelets contributes to hypercoagulability in venoocclusivediseasefollowinghematopoeticstemcelltransptantatJon [ J ] .Thrombosis Research, 2005,116 ( 3 ) : 233 - 240.
  • 7Gallus AS. Management options for thrombophilias [ J ] . Semin Thromb Hemost,2005,31 ( 1 ) : 118 - 126.
  • 8Favaloro EJ. Diagnostic issues in thrombophilia: a laboratory scientist's view [ J ] . SeminThromb Hemost, 2005,31 ( 1 ) : 11- 16.
  • 9Mario Bonomini, Vittorio Sirolli, Gabriele Merciaro, et al. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine [ J ]. Nephrol Dial Transplant, 2005,20 ( 2 ) : 361 - 366.
  • 10M nierodzik, S karpatkin. Hypercoagulabitiy preceding cancer [ J ] . Thrombosis and Haemostasis, 2005,3 ( 3 ) : 577 - 588.

共引文献53

同被引文献259

引证文献13

二级引证文献178

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部